StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck collaboration — Eisai Co., Ltd. (Lenvima Oncology Alliance) ($M) ($M)

Form 10-Q / 10-K Note 3/4 Collaborative Arrangements

Latest, FY2025
241
Period ended Dec 31, 2025
Change on a year earlier
0.0%
241 in FY2024
History
8 years
Since FY2018
Sources
6
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCollaboration — Eisai Co., Ltd. (Lenvima Oncology Alliance) ($M) ($M)Year on yearSource
FY2025Dec 31, 20252410.0%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 2024241-36.7%Form 10-K (filed 2026-02-24) ↗
FY2023Dec 31, 2023381+79.7%Form 10-K (filed 2026-02-24) ↗
FY2022Dec 31, 2022212+8.7%Form 10-K (filed 2025-02-25) ↗
FY2021Dec 31, 2021195-28.0%Form 10-K (filed 2024-02-26) ↗
FY2020Dec 31, 2020271+31.6%Form 10-K (filed 2023-02-24) ↗
FY2019Dec 31, 2019206-85.3%Form 10-K (filed 2022-02-25) ↗
FY2018Dec 31, 20181,400–Form 10-K (filed 2021-02-25) ↗

Breakdown

What makes up collaboration — eisai co., ltd. (lenvima oncology alliance) ($m)

Cite this data

StockData. (2026). Merck Collaboration — Eisai Co., Ltd. (Lenvima Oncology Alliance) ($M) ($M), annual FY2018–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/collab_eisai

See every metric in the Merck KPI table. Data updated Oct 26, 2026.